Brief: Celyad Loss For The Year Narrows To 37.4 Million Euros

Celyad Oncology SA

28/03/2019 20:14

March 28 (Reuters) - CELYAD SA  CYAD.BR :
    * CELYAD REPORTS BUSINESS UPDATE AND FULL YEAR 2018
FINANCIAL AND
OPERATING RESULTS
    * FY REVENUE EUR 3.1 MILLION VERSUS EUR 3.5 MILLION YEAR AGO
    * LOSS FOR THE YEAR EUR 37.4 MILLION VERSUS LOSS OF EUR 56.4
MILLION YEAR AGO
    * WE LOOK FORWARD TO PROVIDING CLINICAL UPDATES FROM BOTH
THE
PHASE 1 THINK AND DEPLETHINK TRIALS THROUGHOUT 2019
    * WE LOOK FORWARD TO ADVANCING MULTIPLE SHRNA-BASED CAR-T
PRODUCT
CANDIDATES TOWARDS THE CLINIC IN 2020
    * TREASURY POSITION OF €49.7 MILLION ($56.9 MILLION) AT
YEAR-END
    * FY OPERATING LOSS EXCLUDING NON-RECURRING ITEMS EUR 38.2
MILLION
VERSUS LOSS OF EUR 26.6MLN YEAR AGO

Source text for Eikon:  ID:nGNX3n55TT 
Further company coverage:  CYAD.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))